Malady Kyle 4

What Happened

• Kyle Malady, EVP and Group CEO — VZ Business for Verizon Communications (VZ), received an award of 84,926 restricted stock units (RSUs) on 2026-02-04. The reported acquisition price is $0 because this is a compensation grant (derivative award), not a market purchase.
• Per the filing footnote, each RSU represents the right to one share of common stock plus accrued dividends and the RSUs are scheduled to vest on December 31, 2027.

Key Details

• Transaction date: 2026-02-04; Form 4 filed: 2026-02-06 (timely filing).
• Transaction type/code: Award/Grant (A) — derivative (RSUs).
• Shares awarded: 84,926 RSUs; reported acquisition price: $0; immediate cash value not realized until vesting/conversion.
• Vesting: Subject to RSU agreement; vesting date stated as December 31, 2027.
• Shares owned after transaction: Not specified in the provided filing details.
• Tax withholding or share-for-share settlement: Not reported in this filing.
• Filing appears timely (reported two days after the award).

Context

• RSUs are compensation awards that convert to common shares (plus accrued dividends) when they vest; no shares were sold or purchased in the open market as part of this transaction.
• Such grants are routine executive compensation and do not by themselves indicate buying or selling intent in the market.